Cardiovascular Disease (CV)

Cardiovascular Disease (CV)
Overview

We have based the selection of topics for our program on the list of medical conditions published in the Candidate Handbook of the Commission for Certification in Geriatric Pharmacy Disease State List (http://www.ccgp.org/sites/default/files/CCGP_ContentOutline2014.pdf). Completion of all of our lessons will provide a strong foundation for preparation to challenge the CGP exam.  


H
owever, you should also visit the CCGP "Candidate Page” at http://www.ccgp.org/candidate  to download the candidate handbook and review all of the details and requirements of the exam.  The page also tells you how to register for the exam when you are ready.

By the year 2030, about 20% of the population will be 65 years of age or older. With this increase in the number of older adults, it is estimated that cardiovascular disease, the leading cause of mortality in this group, will cause about 40% of deaths in the United States.1  A similar mortality rate is expected to occur in Canada. Prevention and management of cardiovascular disease is a significant concern for older patients because physiological changes that occur with aging can affect the incidence of disease and associated outcomes.  This lesson provides an introduction to considerations related to cardiovascular disease prevention and management in an older patient.


Disclosures: The author and reviewers have no conflicts of interest to disclose.


CCCEP logo

$63.60
4.00 CEU
Author

Rosemarie Patodia
BScPhm, BCGP

Reviewers

Tom Smiley
BScPhm, PharmD, CTE

Nora MacLeod-Glover
BScPhm, PharmD

1057-2017-2260-I-P
(Expires: Nov 01, 2018)